Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.In 2024, the actual sales revenue of China's game market has reached 325.783 billion yuan, up 7.53% year-on-year. At the 2024 China Game Industry Annual Conference held today, Sun Shoushan, chairman of China Audio-visual and Digital Publishing Association, introduced that the actual sales revenue of China's game market in 2024 has reached 325.783 billion yuan, up 7.53% year-on-year.The media and game sectors continued to rise, with vision china and Guangdong media having five boards in six days and reading technology in three days and two boards, Fuchun shares, readers' media, Zhewen Internet and celebrities having healthy daily limit, while Kaiying Network, Shengguang Group and Tianlong Group followed suit.
The MSCI Asia Pacific Index fell 1% to 185.63.The concept of starting economy continued to strengthen, and the direction of exhibition and IP economy led the rise. Miao Exhibition, Liard and Guangbo shares rose daily, Fengshang Culture and Zhongqingbao rose by more than 10%, and Tianxiaxiu, Dafeng Industry, Silk Road Vision and Aoya shares were among the top gainers.List of stock repurchases of Hong Kong stocks: 43 stocks were repurchased by the company. On December 12, a total of 43 Hong Kong stocks were repurchased by the company, and the repurchase amount of 8 stocks exceeded HK$ 10 million. Among them, Tencent Holdings, AIA and Samsonite have the largest repurchase amounts, with the company repurchasing HK$ 704 million, HK$ 61,711,300 and HK$ 34,247,500 respectively. As of December 12, 274 Hong Kong stocks have been repurchased by the company this year, and the cumulative repurchase amount of 62 stocks during the year exceeded HK$ 100 million. Among them, Tencent Holdings, HSBC Holdings and AIA have the largest cumulative repurchase amount during the year, with the company repurchasing HK$ 104.602 billion, HK$ 40.706 billion and HK$ 31.059 billion respectively.
The CSI convertible bond index opened lower by 0.03%. Lide convertible bonds rose by more than 7%, and Weipai convertible bonds rose by more than 4%; Z-mode convertible bonds fell by nearly 3%, while Fuxin convertible bonds and Yinxin convertible bonds fell by nearly 2%.The three major stock indexes all fell more than 1%, the Shanghai Composite Index fell 1%, the Shenzhen Composite Index fell 1.28%, the Growth Enterprise Market Index fell 1.49%, and more than 4,100 stocks in the whole market fell.Domestic insurance in Hong Kong stocks and Chinese brokerage stocks fluctuated lower, while domestic insurance in Hong Kong stocks and Chinese brokerage stocks fluctuated lower. Guolian Securities fell more than 5%, followed by New China Life Insurance, China Pacific Insurance, China Life Insurance, China Merchants Securities and china galaxy.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14